Question 1

How is the gut microbiome connected to psoriasis?

Accepted Answer

Research describes four pathways along the gut-skin axis. Gut dysbiosis (an inverted Firmicutes/Bacteroidetes ratio, reduced diversity, and enrichment of E. coli), intestinal permeability with disrupted tight junctions and LPS entering circulation, Treg/Th17 imbalance with IL-17 and IL-22 overproduction, and systemic inflammation reflected in elevated CRP, TNF-alpha, and IL-6. Singla 2025 characterizes the gut-skin axis as a complex, bidirectional interaction between the GI system and skin driven by immune modulation, systemic inflammation, and gut microbiota dynamics.

Question 2

Do probiotics actually improve psoriasis?

Accepted Answer

The evidence supports multi-strain probiotics as adjunctive therapy rather than standalone treatment. Zhu 2024's meta-analysis of 7 RCTs found a mean PASI reduction of -3.09 (p = 0.01) and a CRP reduction of -2.36 (p < 0.0001), while PASI-75 achievement (33.57% vs 23.61%) and quality-of-life scores did not reach statistical significance. Adverse events were not increased versus placebo.

Question 3

Which probiotic strains have the strongest psoriasis data?

Accepted Answer

The landmark 12-week, double-blind, placebo-controlled trial by Navarro-Lopez 2019 (n=90 adults with plaque psoriasis) used a multi-strain formula of B. longum CECT 7347, B. lactis CECT 8145, and L. rhamnosus CECT 8361. In that trial 66.7% of the probiotic group achieved PASI-75 versus 41.9% on placebo (p < 0.05), with lower relapse risk at 6-month follow-up. The protocol suggests 10-50 billion CFU daily for at least 12 weeks.

Question 4

Is a single-strain probiotic enough?

Accepted Answer

Current evidence says no. Suriano 2023 tested L. rhamnosus alone in 103 participants over 6 months and found no significant between-group difference (p = 0.620). Liscano 2025's meta-analysis of 19 studies and 1,104 participants confirmed that multi-strain formulations and synbiotic combinations showed greater efficacy than single-strain preparations.

Question 5

Should I take vitamin D for psoriasis?

Accepted Answer

There is a paradox worth understanding. Psoriasis patients consistently show lower 25(OH)D levels (21.0 vs 27.3 ng/mL, p < 0.00001 in Formisano 2023), and the VITAL trial found vitamin D reduced autoimmune disease incidence by 22%. Yet pooled RCTs have not shown significant PASI improvement from oral vitamin D alone at 3, 6, or 12 months. The reasonable takeaway is to correct deficiency for immune and preventive benefit, not as a standalone skin treatment.

Question 6

How long before the protocol shows results?

Accepted Answer

The protocol sets expectations by phase: digestive improvements in weeks 1-4 with possible initial skin fluctuation, gradual reduction in redness and scaling with declining CRP in weeks 4-8, more significant PASI improvement in weeks 8-12, and consolidation with reduced flare frequency across weeks 12-24. Microbiome restoration is gradual, and the Navarro-Lopez RCT showed strongest results at 12 weeks with sustained benefit at 6 months.

Psoriasis & Skin Health Protocol: Gut-Skin Axis Guide